Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
NCT: NCT03873259 · RECRUITING
Brief Summary
Burst Wave Lithotripsy (BWL) is a novel method of urinary stone fragmentation that uses multi-cycle bursts of low amplitude ultrasound to induce stone fracture. This is in contrast to traditional extracorporeal shock wave lithotripsy (SWL), which employs a brief single compression/tensile cycle of high amplitude (shock) waves to achieve stone fracture. This is a single-arm feasibility study to test the ability of BWL to comminute (fragment) stones in humans.
Frequently Asked Questions
What is Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)?
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL) is a clinical trial registered under NCT03873259. Current status: RECRUITING.
What is the status of NCT03873259?
The current status of NCT03873259 (Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)) is: RECRUITING.
When did Intraoperative Assessment of of Burst Wave Lithotripsy (BWL) start?
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL) started on 2019-08-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.